Vol.

No.

June 04, 2021Jun 04, 2021

Free

DOWNLOAD THE PDF

Dan Hayes witnessed cancer history, now he is documenting it in a podcast

Cover Story

Cancer History Project Free

Dan Hayes witnessed cancer history, now he is documenting it in a podcast

By Alexandria Carolan

Daniel Hayes is racing to record the stories of oncology’s greats.

Free

As Axel Grothey becomes an emblem of sexual misconduct in medicine, many warn that the problem is bigger than one man

By Alexandria Carolan and Paul Goldberg

Free White House

Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H

By Matthew Bin Han Ong

Free In the Archives

Breaking new ground: Nathaniel Berlin, Paul Marks, and Val Skinner

Clinical Free Trials & Tribulations

Precision oncology must evolve to address health disparities

By Brandon Mahal and Jeffrey Venstrom

In Brief

Amy Abernethy named president of clinical research platforms at Verily

John Glick to retire from Penn Medicine

Andrew Aplin named deputy director of Sidney Kimmel Cancer Center – Jefferson Health

Sukhmani Padda named director of Thoracic Medical Oncology at Cedars-Sinai

Amy Jo Jenkins named director of clinical trials administration at UAMS Winthrop P. Rockefeller Cancer Institute

Andrew Schaefer receives $1.2M NCI grant to develop personalized approach to adaptive radiation therapy for head and neck cancers

American Red Cross and American Cancer Society collaborate to encourage donors to Give Blood to Give Time

Clinical Roundup

Lynparza in the adjuvant treatment of patients with germline BRCA1/2 mutations and high-risk early breast cancer reduced the risk of cancer recurrence by 42% in OlympiA phase III trial

Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer

Survey: Cancer patients and survivors continue to face pandemic-related health care delays one year later

Dual immunotherapy regimen delays cancer progression in patients with advanced melanoma

Researchers discover gene linked to bone cancer in children, identify potential novel therapy

Drugs & Targets

Truseltiq receives FDA accelerated approval for metastatic cholangiocarcinoma

Lumakras receives FDA accelerated approval for KRAS G12C mutated NSCLC

European Commission approves Opdivo + Yervoy as first-line treatment for unresectable malignant pleural mesothelioma

NCI Trials

NCI Trials for June 2021

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues